Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.31.1 (
micrococcal nuclease
)
2,818
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have analyzed at both low and high resolution the distribution of nucleosomes over the Saccharomyces cerevisiae
ADH2
promoter region in its chromosomal location, both under repressing (high-glucose) conditions and during derepression. Enzymatic treatments (
micrococcal nuclease
and restriction endonucleases) were used to probe the in vivo chromatin structure during
ADH2
gene activation. Under glucose-repressed conditions, the
ADH2
promoter was bound by a precise array of nucleosomes, the principal ones positioned at the RNA initiation sites (nucleosome +1), at the TATA box (nucleosome -1), and upstream of the ADR1-binding site (UAS1) (nucleosome -2). The UAS1 sequence and the adjacent UAS2 sequence constituted a nucleosome-free region. Nucleosomes -1 and +1 were destabilized soon after depletion of glucose and had become so before the appearance of
ADH2
mRNA. When the transcription rate was high, nucleosomes -2 and +2 also underwent rearrangement. When spheroplasts were prepared from cells grown in minimal medium, detection of this chromatin remodeling required the addition of a small amount of glucose. Cells lacking the ADR1 protein did not display any of these chromatin modifications upon glucose depletion. Since the UAS1 sequence to which Adr1p binds is located immediately upstream of nucleosome -1, Adr1p is presumably required for destabilization of this nucleosome and for aiding the TATA-box accessibility to the transcription machinery.
...
PMID:Chromatin remodeling during Saccharomyces cerevisiae ADH2 gene activation. 862 64
The chromatin structure of the Saccharomyces cerevisiae
ADH2
gene is modified during the switch from repressing (high glucose) to derepressing (low glucose) conditions of growth. Loss of protection toward
micrococcal nuclease
cleavage for the nucleosomes covering the TATA box and the RNA initiation sites (-1 and +1, respectively) is the major modification taking place and is strictly dependent on the presence of the transcriptional activator ADR1. To identify separate functions involved in the transition from a repressed to a transcribing promoter, we have analyzed the
ADH2
chromatin organization in various genetic backgrounds. Deletion of the CCR4 gene coding for a general transcription factor impaired
ADH2
expression without affecting chromatin remodeling. Growing yeast at 37 degrees C also resulted in chromatin remodeling at the
ADH2
locus even under glucose repressing conditions. However, although this temperature-induced remodeling was dependent on the ADR1 protein, no
ADH2
mRNA was observed. In addition, inactivating RNA polymerase II (and therefore, elongation) was found to have no effect on the ability to reconfigure nucleosomes. Taken together, these data indicate that chromatin remodeling by itself is insufficient to induce transcription at the
ADH2
promoter.
...
PMID:Factors affecting Saccharomyces cerevisiae ADH2 chromatin remodeling and transcription. 938 26